SCHEMBL28041433

SCHEMBL28041433

Nc1c(C(=O)Cc2ccccc2)cccc1S(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 1/20 0.42
KDM4E B2RXH2 3/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
AKR1B1 P15121 1/20 0.41
USP2 O75604 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 1/20 0.40
SRD5A2 P31213 2/20 0.39
HIF1A Q16665 1/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10954405 0.81 G6PD (0.52) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL1878465 0.81 KDM4E (0.47) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL3278890 0.79 SMN1; SMN2 (0.49) MEN1KMT2AKDM4ECES2CES1
SCHEMBL3279897 0.79 HTT (0.49) MEN1KMT2ATDP1ALDH1A1CES2
SCHEMBL7129795 0.76 MEN1 (0.62) MEN1KMT2AALDH1A1CES2CES1
SCHEMBL4175858 0.75 KDM4E (0.56) MEN1KMT2ATDP1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL9151636 0.74 KDM4E (0.54) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL2778596 0.73 ALDH1A1 (0.60) TDP1ALDH1A1KDM4EUSP2TP53
SCHEMBL1787541 0.71 USP2 (0.69) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL28114260 0.71 ALDH1A1 (0.58) TDP1ALDH1A1KDM4EUSP2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105111114-A Method for recovering benzene sulfinic acid from drug intermediate GCLE mother solution TIANJIN PHARMACEUTICAL GROUP GENCOM PHARMACEUTICAL 2015-12-02 CN disclosed